4072 related articles for article (PubMed ID: 3810424)
1. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion.
Sutherland CM; Mather FJ; Krementz ET
Surg Gynecol Obstet; 1987 Feb; 164(2):111-8. PubMed ID: 3810424
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy by regional perfusion for limb melanoma.
Krementz ET; Carter RD; Sutherland CM; Muchmore JH
Am Surg; 1987 Mar; 53(3):133-40. PubMed ID: 3103506
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusion.
Di Filippo F; Giacomini P; Rossi CR; Santinami M; Anzà M; Garinei R; Perri P; Botti C; Di Angelo P; Sofra C; Pasqualoni R; Sperduti I; Cavaliere F; Di Filippo S; Corrias F; Armenti A; Ferraresi V; Ginebri A
In Vivo; 2009; 23(2):347-52. PubMed ID: 19414425
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients.
Knorr C; Meyer T; Janssen T; Goehl J; Hohenberger W
Eur J Surg Oncol; 2006 Mar; 32(2):224-7. PubMed ID: 16289716
[TBL] [Abstract][Full Text] [Related]
5. Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion.
Klaase JM; Kroon BB; van Geel AN; van Wijk J; Franklin HR; Eggermont AM; Hart AA
J Am Coll Surg; 1994 Jun; 178(6):564-72. PubMed ID: 8193749
[TBL] [Abstract][Full Text] [Related]
6. Results of cisplatin hyperthermic isolation perfusion for stage IIIA and IIIAB extremity melanoma.
Fletcher WS; Pommier R; Small K
Melanoma Res; 1994 Mar; 4 Suppl 1():17-9. PubMed ID: 8038590
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities.
Boesch CE; Meyer T; Waschke L; Merkel S; Goehl J; Hohenberger W; Knorr C
Int J Hyperthermia; 2010 Feb; 26(1):16-20. PubMed ID: 20100048
[TBL] [Abstract][Full Text] [Related]
8. Improved survival for soft tissue sarcoma of the extremities by regional hyperthermic perfusion, local excision and radiation therapy.
Lehti PM; Moseley HS; Janoff K; Stevens K; Fletcher WS
Surg Gynecol Obstet; 1986 Feb; 162(2):149-52. PubMed ID: 3945892
[TBL] [Abstract][Full Text] [Related]
9. Multiple perfusions for melanoma.
Krementz ET; Muchmore JH; Carter RD; Sutherland CM
Melanoma Res; 1994 Mar; 4 Suppl 1():39-44. PubMed ID: 8038595
[TBL] [Abstract][Full Text] [Related]
10. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
Binder J; Henneking K
Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
[TBL] [Abstract][Full Text] [Related]
11. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
Kroon BB; Schraffordt Koops H
Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177
[TBL] [Abstract][Full Text] [Related]
12. Survival with regional and distant metastases from cutaneous malignant melanoma.
Roses DF; Karp NS; Oratz R; Dubin N; Harris MN; Speyer J; Boyd A; Golomb FM; Ransohoff J; Dugan M
Surg Gynecol Obstet; 1991 Apr; 172(4):262-8. PubMed ID: 2006449
[TBL] [Abstract][Full Text] [Related]
13. [Surgical treatment and regional chemotherapy in melanoma of the extremities].
Henneking K; Binder J; Weyers W; Schwemmle K
Chirurg; 1993 Feb; 64(2):134-8. PubMed ID: 8462350
[TBL] [Abstract][Full Text] [Related]
14. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
15. [Value of regional lymph node excision for prognosis of advanced malignant melanoma treated by perfusion of the extremity].
Huber R; Krüger I; Stützer H
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():118-21. PubMed ID: 9101808
[TBL] [Abstract][Full Text] [Related]
16. Juvenile malignant melanoma.
Reintgen DS; Vollmer R; Seigler HF
Surg Gynecol Obstet; 1989 Mar; 168(3):249-53. PubMed ID: 2919354
[TBL] [Abstract][Full Text] [Related]
17. Isolated limb perfusion for unresectable melanoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic hyperthermic limb perfusion in stage I melanoma.
Krige JE; King HS; Strover RM
Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
[TBL] [Abstract][Full Text] [Related]
19. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
[TBL] [Abstract][Full Text] [Related]
20. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
